Parkinson’s disease is one of the most common disorders of the central nervous system. In Germany alone, some 250,000 people suffer from Parkinson’s. With early diagnosis and treatment tailored to individual needs it is possible to alleviate the symptoms and significantly improve the patient’s quality of life. Important elements in Parkinson’s therapy are L-dopa and the glutamate antagonist amantadine sulfate.
Professionals will find detailed information on Parkinson’s at www.pk-merz.com.
![back to top [link]](skin_img/skin_contentSiteInfo-backToTop-arrow.gif)
Last update: 17 Jun 2009, 12:23
produced by GPM mbH
URL: http://www.merz.com/health/cns-alzheimers/parkinson/
Last update: 17.06.2009, 00:23 Uhr
© 2010 Merz. All rights reserved.